Big Gain For Syndax Pharmaceuticals, Inc.
Fri, Jan 31, 2020 at 05:30 PM
Syndax Pharmaceuticals, Inc. (SNDX:NASDAQ) rocketted at $9.38, representing a gain of 40.8%. On Thu 30 Jan 20, SNDX:NASDAQ hit a New 2-Week Intraday Low of $6.34. The stock appeared on our News Catalysts scanner on Thu 30 Jan 20 at 04:42 PM in the 'BIOTECH' category. From Thu 09 Jan 20, the stock recorded 42.86% Up Days and 33.33% Green Days
About Syndax Pharmaceuticals, Inc. (SNDX:NASDAQ)
Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications.
Top 10 Gainers:
- Myomo, Inc. (MYO:NYSEMKT), 2125.83%
- BOQI International Medical Inc. (BIMI:NASDAQ), 72.32%
- Vaxart, Inc. (VXRT:NASDAQ), 72.11%
- Navistar International Corporation (NAV:NYSE), 52.14%
- CPS Technologies Corporation (CPSH:NASDAQ), 45.92%
- Syndax Pharmaceuticals, Inc. (SNDX:NASDAQ), 40.84%
- NanoViricides, Inc. (NNVC:NYSEMKT), 39.67%
- Stein Mart, Inc. (SMRT:NASDAQ), 34.61%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 34.29%
- Adient plc (ADNT:NYSE), 33.07%